“How’s it been going?”
Across the desk, a follow-up visit, three months into GLP-1 treatment. The honest answer is somewhere between “fine” and “a lot happened, I just can’t line it up.” Was the bad stretch four weeks ago or six? Did the nausea line up with a dose day, or a spicy dinner that had nothing to do with the medication? By the time the ten-minute slot ends, the two things actually worth flagging — a new pattern of afternoon fatigue, a question about a supplement — are back in the parking lot, not in the doctor’s notes.
By the end of this, you will know what is actually worth writing down between visits, how to turn scattered notes into a short list your doctor can act on, and where tracking stops helping and starts adding noise.
Why a Short Visit Struggles to Hold Three Months of Change
Follow-up appointments typically run 10 to 20 minutes. GLP-1 treatment unfolds over weeks — appetite shifts gradually, gut symptoms settle in and out, energy changes in ways that are easy to blame on something else entirely. Memory for slow change is unreliable. You adapt to a gradual shift faster than you notice it happened, which makes it genuinely hard to report accurately from memory alone.
Structured preparation closes some of that gap. Research on giving patients a written question list before a consultation — studied mostly in oncology clinics, where visit time is similarly tight — found that patients who brought a prepared list asked significantly more questions during the visit than those who did not.[1] The clinical setting is different, but the underlying mechanic carries over to any short visit: a specific list prepared in advance beats trying to reconstruct months of experience out loud, under a clock.
What’s Actually Worth Logging Between Visits
Not everything. A log nobody keeps is worse than no log at all. Five categories cover most of what a doctor actually needs to hear.
Gut symptoms. Nausea, constipation, diarrhea, and reduced appetite are common enough on GLP-1 medication that your doctor already expects to discuss them — clinical trial data show nausea occurring in roughly 25% to 45% of patients depending on dose and the specific medication, with diarrhea near 13%, constipation around 7%, and appetite loss near 3%.[2] What’s useful isn’t just “I had nausea” — it’s whether it’s improving, holding steady, or getting worse, and whether it tracks with anything specific, like a dose day or a particular meal.
Injection-site changes. Redness, swelling, a lump that doesn’t resolve, or a site that’s become uncomfortable to use. Easy to dismiss as nothing. Worth a one-line note either way.
Energy and fatigue patterns. Not “I’m tired,” but when — mornings specifically, the day after your dose, or a creeping baseline shift over several weeks.
Appetite and eating changes. Skipped meals, specific foods you can no longer tolerate, or trouble getting enough protein or fluids in. Appetite, nausea, and eating changes often move together, and understanding how those three interact can help you describe what’s actually happening more precisely than “I’m just not eating much.”
When you take it. Not the dose itself — simply whether your timing has stayed consistent, or whether you missed or delayed a dose. This is context for your doctor’s decisions, not a substitute for their guidance on your schedule.
Turning Notes Into Questions
A running note only helps if it becomes something you can hand over or say out loud in under a minute.
Before the visit, scan your notes for patterns — not every isolated bad day, but anything that repeated, worsened, or genuinely concerned you. Pull out three to five. Rewrite each one as a question, not just an observation. “Nausea most Tuesdays” becomes “is the nausea I notice the day after my dose expected at this point, or worth adjusting something for?”
Bring the list on paper or your phone. Handing over even a short written list means the specifics survive the nerves of the appointment — you’re not relying on memory to hold the symptom and the question at the same time. This isn’t about replacing scale-focused tracking, either — a data-driven view of GLP-1 progress looks at body-composition signals over the course of treatment; this is the conversation layer, what to actually say once you’re sitting across from your doctor.
What People Commonly Forget to Mention
A few things patients routinely leave out, usually without meaning to:
- Missed or delayed doses. It can feel like admitting a failure. It isn’t — it’s information your doctor needs to correctly interpret how you’re responding.
- New supplements, over-the-counter medication, or a change in alcohol use since the last visit. Interactions are exactly the kind of thing a doctor is positioned to catch, and you generally are not.
- Mood or sleep shifts you’ve attributed to something else — work stress, a life event. Worth a brief mention anyway. Sorting out coincidence from connection is your doctor’s job, not yours to pre-decide.
- Injection-site issues, for the same reason — people assume it’s normal and don’t think to raise it.
A Caution, Stated Plainly
Tracking helps, but it has two honest limits worth naming.
More tracking is not automatically better. In a large real-world digital weight-loss programme built around tirzepatide, patients who weighed in on a steady weekly rhythm showed better retention and outcomes than those who weighed in very frequently during their first month — frequent early self-weighing was associated with worse retention, not better results.[3] For most people, weekly is enough for weight. Checking daily, watching a number that naturally fluctuates, tends to feed anxiety more than it produces useful information.
A log is also not a diagnosis. Your notes tell your doctor what happened. They don’t tell either of you what it means. One rough week is not a verdict on whether the medication is working — a pattern across several weeks is far more useful than any single data point, and even that pattern is a starting point for a conversation, not a conclusion you’ve already reached before you sit down. Self-tracking prepares the conversation. It doesn’t replace the judgment that happens inside it.
A Simple Structure to Bring
Three columns are enough: what changed, what symptom or side effect came with it, and the question it raises. A notebook or a phone note both work — the format matters less than whether you actually keep it. A few honest lines kept consistently beat an elaborate log abandoned after ten days.
What This Actually Means for Your Next Visit
None of this replaces the conversation itself. It means the time you do have gets spent on the things that genuinely needed a doctor’s judgment, instead of trying to remember what happened in week six while the clock runs.
Keeping a simple record of your symptoms, energy, meals, and questions between visits is what makes that conversation sharper each time — not more work, just less lost in the parking lot afterward.
This article is for education only and does not replace medical advice. Any changes to your GLP-1 treatment, dose, or schedule should be discussed with and directed by your doctor, who can assess your full health history and current condition.
Join the Field Notes
Metabolic Field Notes tracks the evidence as it develops, without protocol-pushing and without hype. If evidence-aware, translational science is useful to you, join the Field Notes.
References
[1] Wang SJ, Hu WY, Chang YC. Question prompt list intervention for patients with advanced cancer: a systematic review and meta-analysis. Support Care Cancer. 2024;32(4):231. DOI: 10.1007/s00520-024-08432-3.
[2] Joy B, Ramsamooj A, Ibrahim S, Wen J, Hsu N, Frezza E. Exploring the rates of gastrointestinal adverse effects among five GLP-1 receptor agonists: a systematic review and meta-analysis. Endocrine. 2026;91(1):23. DOI: 10.1007/s12020-025-04494-3.
[3] Talay L, Hom J, Scott T, Ahuja N. Effectiveness and adherence in a tirzepatide-supported digital weight-loss programme in Australia: a real-world observational study. Diabetes Obes Metab. 2026;28(4):2835-2848. DOI: 10.1111/dom.70462.
